How CRISPR Works: Unpacking the Science of Cas9 and Gene Modification

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Morning Overview on MSN

ARPA-H is building clinical AI agents designed for FDA authorization and trials

The Advanced Research Projects Agency for Health, an agency within the U.S. Department of Health and Human Services, published a new program on January 13, 2026, with an ambitious target: building the ...
Morning Overview on MSN

Study shows immune cells can be engineered inside the body to fight cancer

Scientists have built functional cancer-fighting immune cells directly inside living animals, skipping the expensive and time-consuming process of extracting a patient’s cells and engineering them in ...

This New $7 Million Bet Targets a CNS Drug Maker With Phase 3 Trial Underway and 27% Stock Gain

Axsome Therapeutics develops therapies for central nervous system disorders, with a late-stage pipeline targeting major unmet medical needs.
The Next Web

Rivia raises €13M to bring agentic AI to clinical trials

Zurich-based Rivia raises €13M to expand its agentic AI platform for biotech clinical trials, building on a €3M seed in 2024.

Barinthus Bio Reports Full Year 2025 Financial Results and Updates on Corporate Developments

Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) to create a differentiated company focusing on clinical metabolic and ...

Axsome Therapeutics, Inc. (AXSM) Presents at The Citizens Life Sciences Conference 2026 Transcript

The Citizens Life Sciences Conference 2026 March 10, 2026 4:00 PM EDTCompany ParticipantsMark Jacobson - Chief ...